Spiroimidazolidinone NPC1L1 inhibitors. 1: Discovery by 3D-similarity-based virtual screening
Authors:
- Daniel R. McMastersDMDaniel R. McMasters
- Margarita Garcia-CalvoMGMargarita Garcia-Calvo
- Vladimir MaiorovVMVladimir Maiorov
- Margaret E. McCannMMMargaret E. McCann
- Roger D. MeurerRMRoger D. Meurer
- Herbert G. BullHBHerbert G. Bull
- JeanMarie LisnockJLJeanMarie Lisnock
- Kobporn L. HowellKHKobporn L. Howell
- Robert J. DeVitaRDRobert J. DeVita
- 1 June 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (11) , 2965-2968
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Extracellular loop C of NPC1L1 is important for binding to ezetimibeProceedings of the National Academy of Sciences, 2008
- Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorptionBioorganic & Medicinal Chemistry Letters, 2008
- Ezetimibe analogs with a reorganized azetidinone ring: Design, synthesis, and evaluation of cholesterol absorption inhibitionsBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and in Vitro Evaluation of Inhibitors of Intestinal Cholesterol AbsorptionJournal of Medicinal Chemistry, 2005
- The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Proceedings of the National Academy of Sciences, 2005
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- The Discovery of Ezetimibe: A View from Outside the ReceptorJournal of Medicinal Chemistry, 2003
- Perspectives in Cholesterol-Lowering TherapyCirculation, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663British Journal of Pharmacology, 2000